Medplus Health Services Limited
All news and filings related to Medplus Health Services Limited.
View all news & filings- Low impact
Medplus Subsidiary's Karnataka Store Drug License Suspended for 2 Days
Medplus Health Services Limited's subsidiary, Optival Health Solutions Private Limited, had a drug license for a store in Karnataka suspended for two days. The suspension, effective from May 12, 2026, is expected to result in a revenue loss of approximately ₹0.76 lacs.
Read the summary - Low impact
Medplus Health Services Announces Earnings Call for Q4 FY26 on May 21
Medplus Health Services Limited will host an earnings call on May 21, 2026, at 16:00 IST to discuss audited financial results for the quarter and financial year ended March 31, 2026.
Read the summary - Low impact
Medplus Subsidiary's Drug License Suspended for One Day in Delhi
Medplus Health Services Limited's subsidiary, Optival Health Solutions Private Limited, has had a drug license for one store in Delhi suspended for one day. The suspension is due to alleged violations of the Drugs and Cosmetics Act. A potential revenue loss of ₹0.30 lakh is anticipated.
Read the summary - Low impact
Medplus Subsidiary Receives Two One-Day Drug License Suspensions
Medplus Health Services Limited's subsidiary, Optival Health Solutions Private Limited, received two one-day drug license suspension orders. One order from Nizamabad, Telangana, cited rule violations and a potential revenue loss of ₹0.09 lacs. The other from Bidar, Karnataka, has an estimated revenue loss of ₹0.15 lacs.
Read the summary - Low impact
Medplus Subsidiary's Drug License Suspended for 5 Days in Maharashtra
Medplus Health Services Limited's subsidiary, Optival Health Solutions Private Limited, has had its drug license for a store in Nashik, Maharashtra, suspended for five days. The suspension is due to alleged violations of the Drugs and Cosmetics Act. The company anticipates a potential revenue loss of ₹0.75 lakh.
Read the summary - Medium impact
Medplus Subsidiary's Drug License Suspended for 65 Days in Chhattisgarh
Medplus Health Services Limited's subsidiary, Optival Health Solutions, has had a drug license suspended for 65 days for a store in Chhattisgarh. The suspension, effective May 5, 2026, is due to alleged violations of the Drugs and Cosmetics Act. The company estimates a revenue loss of ₹16.00 lacs.
Read the summary - Low impact
Medplus Subsidiary Receives 3-Day Drug License Suspension in Karnataka
Medplus Health Services Limited's subsidiary, Optival Health Solutions Private Limited, received a three-day suspension of its drug license for a store in Hubli, Karnataka. The order, received on April 30, 2026, is due to alleged violations of the Drugs and Cosmetics Act. A potential revenue loss of ₹0.97 lakh is anticipated.
Read the summary - Medium impact
Medplus Health Services receives two Stay Orders against suspension in Pune
Medplus Health Services Limited received two Stay Orders against a previously announced suspension in Pune, Maharashtra. These orders were issued by appropriate authorities and will be available on the company's and stock exchanges' websites.
Read the summary - Low impact
Medplus Subsidiary's Karnataka Store Drug License Suspended for 5 Days
Optival Health Solutions, a subsidiary of Medplus Health Services, had its drug license for a store in Jayanagar, Karnataka, suspended for five days. The suspension, effective from April 21, 2026, is due to alleged violations of the Drugs and Cosmetics Act. The company anticipates a revenue loss of ₹5.39 lacs.
Read the summary - Low impact
Medplus Subsidiary Receives Two Drug License Suspensions, Potential Revenue Loss of ₹1.25 Lakhs
Medplus subsidiary Optival Health Solutions received two drug license suspensions. A seven-day suspension for a store in Andhra Pradesh may result in ₹0.88 lakh revenue loss. A two-day suspension for a Telangana store could lead to ₹0.37 lakh revenue loss. The company will provide updates on its website.
Read the summary - Medium impact
Medplus Subsidiary's Drug License Suspended in Karnataka, Potential Revenue Loss of ₹4.98 Lakhs
Medplus Health Services Limited's subsidiary, Optival Health Solutions, received two drug license suspension orders in Karnataka. The Jayanagar store faces a four-day suspension, and the Srinivasanagar store faces a five-day suspension, both effective from April 16, 2026. Potential revenue loss is estimated at ₹3.68 lacs and ₹1.30 lacs respectively.
Read the summary - Low impact
Medplus Subsidiary Receives Drug License Suspension Orders for Two Stores
Medplus' subsidiary, Optival Health Solutions, received two drug license suspension orders. One store in Andhra Pradesh faces a seven-day suspension with an estimated revenue loss of ₹5.85 lacs. Another store in Odisha faces a two-day suspension with an estimated revenue loss of ₹0.96 lacs.
Read the summary - Low impact
Medplus Subsidiary Optival Health Solutions Receives 5-Day Drug License Suspension in Odisha
Medplus subsidiary Optival Health Solutions received a 5-day drug license suspension for a store in Odisha. The suspension, effective from April 10, 2026, is due to alleged violations of the Drugs and Cosmetics Act. The company estimates a potential revenue loss of ₹3.80 lacs.
Read the summary - Low impact
Medplus Subsidiary Receives 2-Day Drug License Suspension Order in Telangana
Medplus Health Services Limited's subsidiary, Optival Health Solutions Private Limited, received a two-day suspension order for a drug license in Telangana. The order, effective from April 8, 2026, is due to a violation of the Drugs and Cosmetics Act. A potential revenue loss of ₹0.28 lakh is anticipated.
Read the summary - Low impact
Medplus Health Services Ltd. Submits SEBI Regulation 74(5) Certificate for Q4 FY26
Medplus Health Services Limited submitted a certificate under SEBI Regulation 74(5) for the quarter ended March 31, 2026. The certificate was received from Registrar and Transfer Agents, KFIN Technologies Limited, confirming compliance. The details are available on the company and stock exchange websites.
Read the summary - Low impact
Medplus Subsidiary's Telangana Store Drug License Suspended for 2 Days
Medplus Health Services Limited's subsidiary, Optival Health Solutions, received a two-day suspension order for a drug license of a store in Jangaon, Telangana. The order was received on April 2, 2026, due to alleged violations of the Drugs and Cosmetics Act. A potential revenue loss of ₹0.16 lakh is anticipated.
Read the summary - Low impact
Medplus Subsidiary's Telangana Store Drug License Suspended for 3 Days
Medplus Health Services Limited's subsidiary, Optival Health Solutions, received a three-day suspension order for a drug license of a store in Telangana. The order, received on March 28, 2026, is due to a violation of the Drugs and Cosmetics Act. A potential revenue loss of ₹0.60 lacs is anticipated.
Read the summary - Low impact
Medplus Subsidiary Receives 3-Day Drug License Suspension in Karnataka
Medplus Health Services' subsidiary, Optival Health Solutions, had a drug license for a store in Karnataka suspended for three days. The suspension, effective March 27, 2026, is due to alleged violations of the Drugs and Cosmetics Act. A potential revenue loss of ₹0.66 lacs is anticipated.
Read the summary - Medium impact
Medplus Health Services Shareholders Approve Material Related Party Transactions
Medplus Health Services shareholders approved material related party transactions with subsidiary Optival Health Solutions Private Limited via postal ballot and e-voting. The resolution passed overwhelmingly, with 99.9993% of valid votes in favor. E-voting concluded on March 26, 2026.
Read the summary - Low impact
Medplus Health Services Closes Trading Window from April 1, 2026, for Q4 FY26 Results
Medplus Health Services Limited is closing its trading window from April 1, 2026. The window will reopen 48 hours after the announcement of audited financial results for the quarter and financial year ending March 31, 2026. The board meeting date for approving these results will be announced later.
Read the summary - Low impact
Medplus Subsidiary's Karnataka Store Drug License Suspended for 3 Days
Medplus Health Services Limited's subsidiary, Optival Health Solutions Private Limited, has had its drug license for a store in Mandya, Karnataka, suspended for three days. The suspension, effective from March 21, 2026, is due to alleged violations of the Drugs and Cosmetics Act. A revenue loss of ₹0.37 lacs is anticipated.
Read the summary - Low impact
Medplus Subsidiary Optival Health Solutions Receives 7-Day Drug License Suspension
Medplus Health Services Limited's subsidiary, Optival Health Solutions, received a seven-day suspension order for a drug license for a store in Andhra Pradesh. The suspension is effective from March 20, 2026, and is expected to result in a revenue loss of ₹1.93 lacs.
Read the summary - Low impact
Medplus Subsidiary Receives 5-Day Drug License Suspension in Karnataka
Medplus' subsidiary, Optival Health Solutions, received a five-day suspension for a drug license in Karnataka. The suspension applies to the Lingaraj Nagar store and is expected to result in a potential revenue loss of ₹1.77 lacs. The order was issued by the Drugs Control Administration.
Read the summary - Low impact
Medplus Health Services to Incorporate Wholly Owned Subsidiary for CSR Activities
Medplus Health Services Limited's Board approved the incorporation of a Wholly Owned Subsidiary for CSR activities. The new entity will operate under Section 8 of the Companies Act, 2013, with Medplus holding 100% shareholding. The name has been approved by the Registrar of Companies, Hyderabad.
Read the summary - Low impact
Medplus Subsidiary's Drug License Suspended for 2 Days in Karnataka
Medplus subsidiary Optival Health Solutions' drug license for a store in Bidadi, Karnataka, has been suspended for two days. The order was received on March 14, 2026. This is expected to result in a potential revenue loss of ₹2.88 lacs.
Read the summary - Medium impact
Medplus Subsidiary Receives Three Drug License Suspensions for Stores in Karnataka, Telangana, and Andhra Pradesh
Medplus Health Services Limited's subsidiary, Optival Health Solutions, received three drug license suspension orders. The suspensions are for two days in Karnataka (₹1.07 lacs revenue loss), three days in Telangana (₹1.60 lacs revenue loss), and seven days in Andhra Pradesh (₹2.12 lacs revenue loss). Orders were received on March 13, 2026.
Read the summary - Low impact
Medplus Subsidiary's Odisha Store Faces 3-Day Drug License Suspension
Medplus Health Services Limited's subsidiary, Optival Health Solutions, had a store's drug license suspended for three days in Odisha. The suspension, effective March 9, 2026, is due to alleged violations of the Drugs and Cosmetics Act. A potential revenue loss of ₹1.38 lacs is anticipated.
Read the summary - Low impact
Medplus Subsidiary's Maharashtra Store Drug License Suspended for 7 Days
Medplus Health Services Limited's subsidiary, Optival Health Solutions, had a drug license for a Maharashtra store suspended for seven days. The suspension, effective March 3, 2026, is due to alleged violations of the Drugs and Cosmetics Act. The company anticipates a revenue loss of ₹3.85 lacs.
Read the summary - Low impact
Medplus Subsidiary's Telangana Store Faces One-Day Drug License Suspension
Medplus Health Services Limited subsidiary Optival Health Solutions received a one-day drug license suspension for a store in Telangana. The order, received on February 27, 2026, is due to a violation of the Drugs and Cosmetics Act. The company expects a potential revenue loss of ₹0.42 lacs.
Read the summary - Low impact
Medplus Health Services to Attend Investor Meeting on March 6, 2026
Medplus Health Services Limited's Key Managerial Personnel will attend a virtual investor meeting organized by Nirmal Bang on March 6, 2026. No Unpublished Price Sensitive Information will be disclosed.
Read the summary - Low impact
Medplus Subsidiary Receives 7-Day Drug License Suspension for Andhra Pradesh Store
Medplus' subsidiary, Optival Health Solutions, received a 7-day suspension for a drug license of a store in Guntur, Andhra Pradesh. The order was received on February 25, 2026, due to a violation of the Drugs and Cosmetics Act. The company anticipates a revenue loss of ₹2.22 lakhs.
Read the summary - Low impact
Medplus Health Services Limited Publishes Newspaper Advertisement for Postal Ballot Notice Dispatch
MedPlus Health Services Limited has published a newspaper advertisement confirming the completion of dispatch for its Postal Ballot Notice. The advertisement appeared in the Financial Express and Nava Telangana on February 25, 2026. Information is also available on company and exchange websites.
Read the summary - Medium impact
Medplus Health Services seeks approval for material related party transactions worth ₹1126.22 crore
Medplus Health Services is seeking member approval for material related party transactions worth ₹1,126.22 crore with its subsidiary, Optival Health Solutions, for FY 2026-27. Remote e-voting will be open from Feb 25 to March 26, 2026. These transactions exceed 10% of the company's consolidated turnover.
Read the summary - Low impact
Medplus Subsidiary Receives 3-Day Drug License Suspension in Telangana
Medplus Health Services Limited's subsidiary, Optival Health Solutions Private Limited, has had its drug license suspended for three days for a store in Telangana. The suspension, effective February 22, 2026, is due to alleged violations of the Drugs and Cosmetics Act. The company estimates a potential revenue loss of ₹0.76 lacs.
Read the summary - Low impact
Medplus Subsidiary Optival Receives Two Drug License Suspensions in Karnataka
Medplus subsidiary Optival Health Solutions received two drug license suspension orders in Karnataka. One store in Vinobha Nagar faces a five-day suspension, with an estimated revenue loss of ₹1.40 lacs. Another store in KSRTC Davanagere faces a seven-day suspension, with an estimated revenue loss of ₹2.79 lacs.
Read the summary - Low impact
Medplus Subsidiary Receives One-Day Drug License Suspension in Karnataka
Medplus Health Services Limited's subsidiary, Optival Health Solutions Private Limited, had one store's drug license suspended for one day in Karnataka. The suspension order was received on February 19, 2026. The company anticipates a potential revenue loss of ₹0.33 lacs.
Read the summary - Low impact
Medplus Subsidiary Faces 7-Day Drug License Suspension in Andhra Pradesh; ₹4.28 Lakh Revenue Impact
Medplus Health Services Limited's subsidiary, Optival Health Solutions Private Limited, received a seven-day suspension order for a drug license of a store in Andhra Pradesh. The order, received on February 12, 2026, is expected to result in a potential revenue loss of ₹4.28 lakhs.
Read the summary - Low impact
Medplus Subsidiary Optival Health Solutions Receives 15-Day Drug License Suspension in Maharashtra
Medplus subsidiary Optival Health Solutions received a 15-day drug license suspension for a store in Pune, Maharashtra. The order was received on February 03, 2026, due to alleged violations of the Drugs and Cosmetics Act. The company anticipates a revenue loss of ₹6.27 lakhs.
Read the summary - Medium impact
Medplus Q3 FY26 Earnings Call Transcript Released
Medplus Health Services Limited released its Q3 FY26 earnings call transcript. The company added 182 net stores in the quarter, reaching 5,112 total stores. Consolidated revenue was ₹18,061 million, with operating EBITDA at ₹96.8 crore. Pharmacy revenue grew 15.6% YoY. Private label sales were 22.2% of total revenue.
Read the summary - Low impact
Medplus Health Services Submits Audio Recordings of Q3FY26 Earnings Call
MedPlus Health Services released audio recordings of its Q3FY26 earnings call held on February 02, 2026. The call discussed financial results for the quarter ended December 31, 2025, with analysts and institutional investors. Recordings are available on the company and exchange websites.
Read the summary - Low impact
Medplus Subsidiary Receives 25-Day Drug License Suspension in Maharashtra
Medplus Health Services Limited's subsidiary, Optival Health Solutions Private Limited, has had its drug license suspended for 25 days in Maharashtra. The suspension is for a store in Bhandara, Maharashtra, due to alleged violations of the Drugs and Cosmetics Act. A potential revenue loss of ₹7.53 lakhs is anticipated.
Read the summary - Medium impact
Medplus Health Services Limited Announces Q3 FY26 Financial Results and Shareholder Meeting
Medplus Health Services Limited announced Q3 FY26 results on Jan 31, 2026. Key events include a board meeting on Feb 25, 2026, and a shareholder meeting on Mar 27, 2026, for FY25-26 results and dividend declaration. A demerger of the retail pharmacy business into Medplus Wellness Limited is also planned, aiming for completion by Mar 31, 2027.
Read the summary - High impact
Medplus Health Services Q3FY26 Revenue Rises 15.7% YoY to ₹18,061 Crore
Medplus Health Services reported Q3 FY2026 revenue of ₹18,061 million, up 15.7% YoY. Gross Margin increased by 110 bps to 26.2%. The company added 182 net stores, reaching a total of 5,112. Operating Cash Flow was ₹905 million. An investor presentation detailed these results.
Read the summary - Low impact
Medplus Health Services Allots 2,32,061 Equity Shares Under ESOP 2021
Medplus Health Services Limited allotted 2,32,061 equity shares under its ESOP 2021 on January 30, 2026. The allotment increased the paid-up share capital to 12,00,54,642 equity shares, aggregating ₹24,01,09,284. The shares were exercised at ₹628 and ₹232.
Read the summary - Medium impact
Medplus Health Services Q3 FY26 Results: Profit Up, ESOP Allotment
MedPlus Health Services reported Q3 FY26 results with consolidated revenue at ₹18,061 crore and net profit at ₹578 crore. Standalone revenue was ₹2,230 crore with a net profit of ₹166 crore. The company also approved the allotment of 2,32,061 ESOP shares.
Read the summary - Low impact
Medplus Subsidiary Receives One-Day Drug License Suspension in Telangana
Medplus' subsidiary, Optival Health Solutions, received a one-day drug license suspension for a store in Telangana. The action, based on the Drugs and Cosmetics Act, is expected to result in a revenue loss of ₹0.20 lacs. The company has made this information available on its website and stock exchange portals.
Read the summary - Low impact
Medplus Subsidiary's Drug License Suspended for 7 Days in Andhra Pradesh
Medplus Health Services Limited's subsidiary, Optival Health Solutions Private Limited, had a drug license for one store in Andhra Pradesh suspended for seven days. The suspension, effective from January 27, 2026, is expected to cause a revenue loss of ₹2.38 lacs.
Read the summary - Low impact
Medplus Subsidiary's Telangana Drug License Suspended for 3 Days, Impacting Revenue by ₹2.94 Lakhs
Medplus Health Services Limited's subsidiary, Optival Health Solutions Private Limited, had a drug license for a Telangana store suspended for three days. The suspension, effective January 24, 2026, is expected to cause a revenue loss of ₹2.94 lakhs. The action was taken by the Drugs Control Administration under the Drugs and Cosmetics Act.
Read the summary - Medium impact
Medplus Health Services Subsidiary Faces Income Tax Review Petition on ₹43.45 Crore Dispute
Medplus Health Services' subsidiary, Optival Health Solutions, is involved in a tax dispute of ₹43.45 Crores for AY 2020-21. The Income Tax Department filed a review petition on December 23, 2025, against a Telangana High Court order favorable to the subsidiary. The company received intimation on January 07, 2026.
Read the summary - Low impact
Medplus Subsidiary Optival Health Solutions Faces 3-Day Drug License Suspension in Odisha
Medplus subsidiary, Optival Health Solutions, had a drug license suspended for three days for a store in Odisha. The suspension by the Drugs Control Administration is due to alleged violations of the Drugs and Cosmetics Act. The estimated revenue loss is ₹1.26 lakh.
Read the summary
Model portfolios
Filings are the raw material. These are what SEBI-registered experts build from them.
- Stocks
All-Terrain
One equity portfolio instead of three: large, mid and small cap in a single book.
Moderate-Aggressive34 holdings3+ yearsView portfolio - Stocks
Core Compounders
Companies that have already been through a downturn and came out still growing.
Moderate20 holdings3+ yearsView portfolio - Stocks
Udaan
Fast-growing, less-covered companies still early in their runway.
Aggressive29 holdings5+ yearsView portfolio - Stocks
Bharat Rising
Built around India's own shifts: capex, household savings, energy and consumption.
Moderate-Aggressive25 holdings3+ yearsView portfolio